Medicines Co. Stock
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
Cons
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Repligen Corp. | 0.420% | -9.150% | -17.889% | -23.005% | -15.761% | -33.611% | -35.586% |
| Opko Health Inc. | 1.860% | 2.651% | 0.445% | -30.255% | -4.806% | -16.776% | -75.503% |
| Amicus Therapeutics Inc. | -0.830% | 0.840% | 0.000% | 29.032% | 0.000% | -1.736% | -28.144% |
Comments
News
Why Revolution Medicines Stock Plummeted by Almost 17% Today
Monday was generally a good day for the stock market; nevertheless, some titles landed in negative territory. One that plunged well into the red was clinical-stage biotech Revolution Medicines
Why Revolution Medicines Stock Surged by 11% Today
More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That was the dynamic behind the nearly 11% price gain of Revolution Medicines
Why Praxis Precision Medicines Stock Popped Today
Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor


